Cancer diagnostic rates during the 2020 'lockdown', due to COVID-19 pandemic, compared with the 2018-2019: an audit study from cellular pathology

J Clin Pathol. 2021 Mar;74(3):187-189. doi: 10.1136/jclinpath-2020-206833. Epub 2020 Jun 19.

Abstract

Aims: We performed an audit to evaluate the impact of the COVID-19 pandemic-related delay in the diagnosis of major cancers at a Pathology Unit of a Secondary Care Hospital Network in Italy.

Methods: A comparison was made among the number of first cellular pathological diagnoses of malignancy made from the 11th to the 20th week of the years 2018-2020.

Results: Cancer diagnoses fell in 2020 by 39% compared with the average number recorded in 2018 and 2019. Prostate cancer (75%) bladder cancer (66%) and colorectal cancer (CRC; 62%) had the greatest decrease. CRC was identified as carrying a potentially important diagnostic delay.

Conclusions: For CRC corrective procedures (continuing mass screening tests; patient triage by family physicians; diagnostic procedures alternative to colonoscopy; predictive evaluation on biopsy samples) were advised. Our simple audit model is widely applicable to avoid pandemic-related delay in clinical diagnosis of cancer.

Keywords: clinical audit; colorectal neoplasms; diagnosis; epidemiology; infections.

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • Delayed Diagnosis / trends*
  • Early Detection of Cancer / trends*
  • Humans
  • Italy / epidemiology
  • Medical Audit
  • Neoplasms / diagnosis*
  • Neoplasms / epidemiology
  • Pandemics
  • Pathology, Clinical / trends*
  • Physical Distancing*